Innate immune responses are blunted in smokers which make them susceptible to bacterial colonisation of the lungs, such as occur in COPD (Wedzicha, J et al 2003). We have previously shown that cigarette smoke profoundly inhibits the ability of macrophages to release nitric oxide and express NOSII in response to Gram negative bacteria and to LPS (Fleet et al., 2003). Cigarette Smoke Extract (CSE) is comprised of 6000 different components many of which are toxic and likely to interfere with innate immune response. Recently, nicotine has been shown to inhibit LPS induced release of TNF J774 macrophages were plated at 100,000/well in 96-well plates in DMEM containing 10% foetal calf serum. Cells were left to adhere for 3-6 hours before the addition of nicotine (10-5M) or N-acetylcystine (10-3M). After 30 minutes cells were treated with LPS (1 µg/ml), in some cells CSE (2.5 or 5%) was added prepared according to Walters et al., (2003). Briefly CSE (100%) was made by bubbling mainstream cigarette smoke from 4 Marlboro cigarettes into 100mls DMEM. This was then filter sterilised and diluted with non-smoked medium to the desired concentration. Cells were incubated at 37 OC in an atmosphere of 5% CO2 95% air for 24h hours. Nitrite was then measured using the Griess reaction as an indicator of NOSII activity.
Figure 1; Effects of nicotine (Nic, 10-5M), N-acetylcysteine (NAC, 10-3M) or cigarette smoke extract (CSE; 2.5 or 5%) in the presence or absence of NAC on NO release by J774 macrophages treated with LPS (1 mg/ml). Data is the mean ± S.E.M. for n=9 experiments from 3 experimental days. Nicotine (10-7 to 10-5M; 10-5M shown, Figure 1) had no effect on LPS-induced nitrite release. NAC Fleet, MR et al., (2003) Br. J. Pharmacol., 2003; 4P; vol 140 |